Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Embryonal Tumor With Abundant Neuropil and True Rosettes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT01861990
What this trial is testing

Valproic Acid in Childhood Progressive Brain Tumors

Who this might be right for
Pediatric Brain TumorGliomaAnaplastic Astrocytoma+2 more
Medical University of South Carolina
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Early research (Phase 1)Study completedNCT00880308
What this trial is testing

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor CancersMedulloblastomaBasal Cell Carcinoma
Novartis Pharmaceuticals 103
Testing effectiveness (Phase 2)UnknownNCT00180791
What this trial is testing

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Who this might be right for
MedulloblastomaBrain TumorsNeuroectodermal Tumors, Primitive
Gustave Roussy, Cancer Campus, Grand Paris 71
Early research (Phase 1)Looking for participantsNCT06514898
What this trial is testing

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

Who this might be right for
Recurrent Group 3 MedulloblastomaRecurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma
University of Florida 12
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Not applicableUnknownNCT00349024
What this trial is testing

Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChordomaKidney Cancer+7 more
Children's Cancer and Leukaemia Group 50
Testing effectiveness (Phase 2)Ended earlyNCT01374451
What this trial is testing

Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET

Who this might be right for
Islet Cell Tumor
Novartis Pharmaceuticals 160
Testing effectiveness (Phase 2)Study completedNCT00002560
What this trial is testing

Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00003203
What this trial is testing

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Who this might be right for
Brain TumorsCentral Nervous System TumorsNeuroblastoma
Children's Oncology Group 168
Early research (Phase 1)Study completedNCT02982941
What this trial is testing

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaOsteosarcoma+3 more
MacroGenics 25
Not applicableLooking for participantsNCT00898638
What this trial is testing

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 8,000
Testing effectiveness (Phase 2)Ended earlyNCT01505608
What this trial is testing

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
Giselle Sholler 14
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01868490
What this trial is testing

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

Who this might be right for
CholangiocarcinomaNeuroblastoma
Siriraj Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00276679
What this trial is testing

Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Early research (Phase 1)UnknownNCT05782959
What this trial is testing

Phase 1 Study of BCD-245 in Subjects With Neuroblastoma

Who this might be right for
Neuroblastoma
Biocad 24
Post-approval studies (Phase 4)Active Not RecruitingNCT02875314
What this trial is testing

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

Who this might be right for
MedulloblastomaCentral Nervous System Embryonal Tumors
Parth Patel 250
Not applicableLooking for participantsNCT04253015
What this trial is testing

A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

Who this might be right for
Neuroblastoma
RECORDATI GROUP 125
Next Page